Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

iCo Therapeutics Inc V.ICO

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  ICOTF

ICO Therapeutics, Inc. is a development stage pharmaceutical company engaged in the reprofiling and repositioning of drugs and drug candidates with a previous clinical history for new disease indications.
Price: $0.05 | Change: $0.00 | %Change: 0.00%
Volume: 108,527 | Day High/Low: 0.05/0.045 | 52 Week High/Low: 0.59/0.045
View modes: 
5 stars

.045 low for the day

Well thats not the way to go, .045 low for the day and year!! All signs point to .10 cent and higher, what the fudge is going on.?  Please get us out of the basement ICO managment...Hopefully more
0 stars

RE:RE:Good for a purchase at 5

I did no such thing. Must be another hopeful person who can see what I see in this company. Right now this stock is priced with no hope built in for ICO-007. If the company proves otherwise this more
0 stars

RE:Good for a purchase at 5

2015 y did u give urself 5 stars?  rate and reply
0 stars

Better purchase next week when its below 5

No action here just people with weak hands selling off....  rate and reply
5 stars

Good for a purchase at 5

More data coming out for the 12-month period, should be in the first half of October. If there is something, anything that suggest some use for ICO-007 out of this, it will send the stock flying.  rate and reply
0 stars


Insider buying last month looking to be token purchases at best, hell I've boughton more than that, sure hope I don't get burned here, at my witts end with investing in the Vancouver!!!  rate and reply
0 stars

RE:Immune Pharmaceuticals: Phase II Bertilimumab Trials

Good one I'm thinking about to get in as well ?? ICO can be good investment on the long run?? Also have a look @ AVNR have a good potencial as well.... Mark  rate and reply
0 stars

News Release Timeline

July 30th   Announces today that it has initiated the screening of patients for a Phase II proof of concept clinical trial exploring the safety and efficacy of bertilimumab in the treatment more
0 stars

Immune Pharmaceuticals: Phase II Bertilimumab Trials

Here is something that we can chew on. The depressed stock price promted me to read the MD&A and the corporate presentation. I like the stock and bought in. This one is definitely worth more more
0 stars

30 Days ago!!

Well thirty days ago was the last time the insiders bought and we saw .085 cents on the news on the 18th of Aug, bottoming here at .055 again!! Would sure like to see some news to get us to .10 more
0 stars

RE:RE:Flat lined

I would love to invest in something else, but after sitting on this one since June 9th I would like to take some profits before moving on. We're all in this game to make money.  rate and reply
0 stars

RE:Flat lined

what do you mean patience is thin? how much thinner can it get with a $0.055 bid? maybe you need to find something else to invest your money into.   these are my thoughts, not yours, i' more
0 stars

Flat lined

Wow... flat lined at .06 again. Come on... let see some volume to push this one up to .10! Patience on this one is getting thin.  rate and reply
0 stars

They are selling MZO and buying ICO

Time ET Ex Price Change Volume Buyer Seller Markers 12:11:41 V 0.06   3,000 more
0 stars

Canaccord is buying today

Go ICO  rate and reply
0 stars

RE:Stock is very cheap

I agree with every thing you say except for that ico is worth .10. Stocks are an investment and as such need potential upside. As of now ico has not put forth a plan with any upside. we are waiting more
0 stars

Newly Nasdaq-Listed Immune Pharma Offers Big Upside ($9 TGT) Newly Nasdaq-Listed Immune Pharma Offers Big Upside Aug. 25, 2014 3:25 PM ET  | more
0 stars

Stock is very cheap

The balance sheet says $6,590,644 in current assets against $2,674,932 in current liabilities for $3,915,712 in net cash and other working capital items. Also recorded is $1,939,738 in more
0 stars

RE:RE:RE:In 3 weeks we should have a much higher number.

Based on the latest financials the stock is worth $0.075 in cash. Future mile stone payments and there shares in immune may put there value some where in the $0.12 range but with out a solid more
0 stars

RE:RE:In 3 weeks we should have a much higher number.

In 3 weeks we will find a new support point at .12 cents PS at least ...IMHO...soo there is my guess...your guess is as good a mine  rate and reply